Aligos Therapeutics Inc (ALGS)
19.46
+0.01
(+0.05%)
USD |
NASDAQ |
Nov 14, 16:00
19.40
-0.06
(-0.31%)
After-Hours: 20:00
Aligos Therapeutics Shareholders Equity (Quarterly): 50.10M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 50.10M |
| June 30, 2024 | 67.23M |
| March 31, 2024 | 59.80M |
| December 31, 2023 | 92.08M |
| September 30, 2023 | 54.82M |
| June 30, 2023 | 69.64M |
| March 31, 2023 | 84.75M |
| December 31, 2022 | 103.90M |
| September 30, 2022 | 122.01M |
| June 30, 2022 | 136.98M |
| Date | Value |
|---|---|
| March 31, 2022 | 152.89M |
| December 31, 2021 | 184.73M |
| September 30, 2021 | 217.01M |
| June 30, 2021 | 168.88M |
| March 31, 2021 | 195.22M |
| December 31, 2020 | 220.04M |
| September 30, 2020 | -136.67M |
| June 30, 2020 | 121.96M |
| December 31, 2019 | -64.89M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-136.67M
Minimum
Sep 2020
220.04M
Maximum
Dec 2020
100.02M
Average
103.90M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Haemonetics Corp | 878.85M |
| Pliant Therapeutics Inc | 345.82M |
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 6.102M |
| IGC Pharma Inc | 7.88M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 88.43M |
| Total Liabilities (Quarterly) | 38.33M |
| Current Ratio | 3.809 |